Perspective Therapeutics, Inc.
CATX· NYSE
CATXPerspective Therapeutics, Inc.
Filed Sep 29, 2014 · 10-K · 91 days after period end · 0001144204-14-058408
| Metric | Q4 2014 | Q4 2013dderived from reported figures | Q4 2012dderived from reported figures | Q4 2011dderived from reported figures |
|---|---|---|---|---|
| Revenue | $949.52K | $1.24M | $1.31M | $1.26M |
| Net Income | -$1.68M | -$993.56K | -$1.21M | -$712.00K |
| EPS Diluted | -$0.04 | — |
Perspective Therapeutics, Inc. · CIK 728387 · Engraved from SEC EDGAR
| — |
| — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Jun 30, 2014 · filed Sep 29, 2014 · 91 d after period end
